XML 24 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
COST OF GOODS SOLD $ (9,302) $ (15,231) $ (8,398)
RESEARCH AND DEVELOPMENT EXPENSES (35,534) (32,170) (30,412)
Less - grants 2,204 3,336 5,804
RESEARCH AND DEVELOPMENT EXPENSES, NET (33,330) (28,834) (24,608)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (10,916) (11,530) (9,356)
OPERATING LOSS (19,308) (34,517) (33,163)
FINANCIAL EXPENSES (7,685) (9,725) (4,192)
FINANCIAL INCOME 536 188 589
LOSS FROM CHANGE IN FAIR VALUE OF CONVERTIBLE NOTES EMBEDDED DERIVATIVE   (38,061) (6,473)
(LOSS) GAIN ON EXTINGUISHMENT OF CONVERTIBLE NOTES   (1,325) 14,063
FINANCIAL (EXPENSES) INCOME - NET (7,149) (48,923) 3,987
LOSS FROM CONTINUING OPERATIONS (26,457) (83,440) (29,176)
LOSS FROM DISCONTINUED OPERATIONS     (189)
NET LOSS FOR THE YEAR $ (26,457) $ (83,440) $ (29,365)
NET LOSS PER SHARE OF COMMON STOCK – BASIC AND DILUTED      
Loss from continuing operations $ (0.18) $ (0.64) $ (0.29)
Loss from discontinued operations     0.00
Net loss per share of common stock $ (0.18) $ (0.64) $ (0.29)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE OF COMMON STOCK, BASIC AND DILUTED 147,135,182 131,085,958 101,387,704
Goods [Member]      
REVENUES $ 8,978 $ 19,242 $ 9,199
License and R&D Services [Member]      
REVENUES $ 25,262 $ 1,836